Richard Dwayne Blair is the owner of Wealth Solutions, which is an institution helping people find their own path to financial freedom and generational wealth. Ever since Richard was a kid he was inspired by his mother and grandmother who were both teachers. He learned from an early age that teaching improves people’s lives and adds confidence to both participants at the same time. At a young age Richard Dwayne Blair also possessed an innate aptitude for the world of finance, thus leading to his career launch at the financial industry in 1993. In just one year
Richard founded Wealth Solutions in 1994, making it his personal goal to aid and help others achieve their own financial goals, and in the process make brighter financial futures to the people who became his clientele. There are three pillars to success that Richard Dwayne Blair firmly teaches his clients. The first of which is the process of actually finding out what the individual’s goals and strengths are, in order to correctly identify what it is the client wants, the rest of the steps can easily be done much better.
The second pillar Richard teaches is the process of actually working towards the goal the client disclosed by implementing various strategies which compound interest during high markets, and hedge against any nose dives the market takes on during the whole growth progress. This is how a lot of the wealth is built over time and Albert Einstein even calls it the eighth wonder of the world. Lastly the third pillar consists of getting insured so that in case of an emergency happening, the client is covered financially without having to dip into unnecessary funds to pay off the expenses it would take to get things stable again. With all this being said, Richard Dwayne Blair thus stands out as the man with a financial plan.
David Giertz is the president of Nationwide Financial Sales and Distribution Organization. He lays down some meaningful tips on desirable retirement saving that will enable one to enjoy a good life as well as a perfect future. Many people take early retirement without a good plan for their future life and end up living miserably. Early planning for retirement is very vital. It is advisable to save some of your income into retirement accounts. One is advised to have a number of income generating avenues to materialize this.
Investment is another crucial factor that you are supposed to consider since it is the gateway to your financial freedom. The more you invest, the more your extra income, and subsequently higher savings. Before you take an early retirement, you are supposed to consider the amount you have in your account and whether it is going to be enough for your retirement needs. You should also consider your best retirement plan.
If you want to secure a financially stable retirement plan, you are advised to complete your savings account with a brokerage account. This gives you a leeway to access your currencies, stocks and bond markets where you can purchase and sell these commodities for profits. The brokerage accounts tend to give you more flexibility without any limitations; this is during withdrawal and also investment amounts. Saving extra cash in a health savings account is very vital, though it should only be limited to conditional medical expenses to avoid penalties.
David Giertz has been at the helm of Nationwide Financial Sales and Distribution from March 2013. He is also the head, senior vice president and director of several other nationwide companies. He has over 30 years of experience in the field of progressive financial services.
David is an alumnus of Millikin University, where he graduated with a Bachelor of Science degree. He also attended University of Miami, where he graduated with an MBA. He is a certified business coach who is recognized by World Association of Business Coaches. It is worth noting that this prolific man has also attained great recognition from world accredited bodies.
Presently the CEO and president of CNS Bioscience, Mathew Autterson is an exciting business person. Having spent over 25 years as a leader in the financial community, there is a lot to learn from this established business figure. His good qualities stretch beyond the business heights. He is known to have philanthropic interest following the many years he spent serving people.
Mr. Matthew Autterson attended Michigan State University and graduated in 1980 with a Bachelor of Arts Degree in Finance. Besides this, Mathew took a tax program at the University of Denver. His excellent academic background contributes towards his impressive business portfolio and years of business leadership. His educational credentials are said to be remarkable, no wonder his successive business career.
Mr. Autterson began his professional journey early, immediately after school. He began his proficient career at First Trust Corporation. Here he was able to grow both as a person and as a leader. In 1982, he decided to seek further career test. He left First Trust and joined a chartered corporation in Colorado. The New York based Integrated Resources Inc. supplied Mathew with an opportunity to enhance his business leadership expertise. Due to hard work and determination, he was promoted to be the president in 1986.
In 1989, Integrated Resource Inc.’s assets were acquired by a company known as Broad Inc., which later changed to Sun America Inc. Mr. Autterson was also an active leader and board member of Denver Zoological Foundation and the Denver Hospice. Here he was able to fully engage with the zoo world and develop qualities different from the norm. His philanthropic nature is believed to have been engineered here. Currently, he is the president and CEO of Falci Adaptive Bio-systems (FAB). His major qualities include leadership, corporate mentorship, and philanthropy. He is also the CEO and president of CNS Bioscience.
Mathew is an active member of the board of directors of the Colorado based FAB. Here, he is able to express his philanthropic qualities. Besides FAB, he is also an active board member, CEO, and President of CNS Bioscience. The company is known to develop Neuropathy management drugs primarily at the clinical stage.